Real-time Intervention for Suicide Risk Reduction

Status Recruiting

Clinical Trial Summary

The aim of this study is to determine whether learning three skills for managing negative emotions and receiving reminders via smartphone to practice these skills reduces how often and how intensely one experiences emotional distress and suicidal thoughts.

Clinical Trial Description

The present study is a two-arm parallel design RCT to test the efficacy of using ecological momentary intervention (EMI) to deliver therapeutic content based on the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP) - an evidence-based transdiagnostic cognitive behavioral therapy (CBT) that focuses on delivering adaptive skills for managing strong emotions. Participants in this study will be 50 adult psychiatric inpatients with recent suicidal thoughts or behaviors (STBs). Participants will be randomized to receive either the control condition, which consists of treatment as usual (TAU; n = 25) and 4x/daily daily ecological momentary assessment (EMA) of emotions and STBs, or the experimental condition, consisting of TAU, 4x/daily EMA, 3 brief sessions to deliver CBT skills (mindful emotion awareness, cognitive flexibility, and changing emotional behaviors, all drawn from the UP), one discretionary skills booster session, and EMI to prompt guided skills practice (n = 25). Control participants will receive TAU and be prompted to complete 4x/day EMA of emotions and STBs for the duration of their hospital stay and the 28-day post-discharge period. Participants randomized to the experimental conditions will receive TAU plus three brief treatment sessions delivering core UP skills content (during inpatient stays) and a discretionary booster session to reinforce treatment sessions that may be offered after discharge via either phone or telehealth. Those in the experimental condition will also receive training to use the EMI (which prompts guided skills practice), followed by smartphone-based EMA/EMI for the duration of the inpatient stay and the 28-day post-discharge period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05848089
Study type	Interventional
Source	Massachusetts General Hospital
Contact	Kate Bentley, PhD
Phone	617-724-7741
Email	kbentley@mgh.harvard.edu
Status	Recruiting
Phase	N/A
Start date	September 25, 2023
Completion date	October 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05334381` - Navigating Mental Health Treatment for Black Youth	N/A
Recruiting	`NCT04653337` - Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression	Phase 2
Terminated	`NCT04254809` - Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Recruiting	`NCT05280756` - Home-based tDCS for Prevention of Suicidal Ideation	N/A
Completed	`NCT01944293` - Ketamine for Suicidality in Bipolar Depression	Phase 1/Phase 2
Completed	`NCT02021344` - Mental Health First Aid for College Students	N/A
Not yet recruiting	`NCT04686162` - Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy	N/A
Recruiting	`NCT05377177` - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI	N/A
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT05925322` - Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality	N/A
Not yet recruiting	`NCT05427734` - Treating Drivers of Suicide Using Jaspr Health	N/A
Recruiting	`NCT04112368` - Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach	Phase 4
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Recruiting	`NCT05537376` - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness	N/A
Not yet recruiting	`NCT06019650` - Culturally Adapted Suicide Prevention Intervention for Older Adults	N/A
Not yet recruiting	`NCT05860257` - Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction	N/A
Recruiting	`NCT05485701` - Perinatal Mental Health Study (PMHS) India
Recruiting	`NCT05555927` - Adjunctive Duration-doubled tDCS for the Treatment of Depressive Patients With Suicidal Ideation	N/A
Not yet recruiting	`NCT05229302` - Effectiveness of a CBT Online-based Program to Reduce Suicide Ideation Among School Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.